EC

Ecolab IncNYSE ECL Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

72.347

Mega

Exchange

XNYS - New York Stock Exchange, Inc

ECL Stock Analysis

EC

Neutral

Based on Eyestock quantitative analysis, ECL`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

81/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

15.8 %

Greatly undervalued

Market cap $B

72.347

Dividend yield

1.11 %

Shares outstanding

284.46 B

Ecolab, Inc. engages in the provision of products and services in the field of water, hygiene, and energy. The company is headquartered in Saint Paul, Minnesota and currently employs 47,000 full-time employees. The firm delivers various solutions, data-driven insights and personalized service to various industries. Its segments include Global Industrial, Global Institutional & Specialty and Global Healthcare & Life Sciences. Its Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions, primarily to industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government, education and retail industries. Its Global Healthcare & Life Sciences segment provides specialized cleaning and sanitizing products to the healthcare, personal care and pharmaceutical industries.

View Section: Eyestock Rating